Internal hazards: Baseline DNA damage by endogenous products of normal metabolism

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 443, Issue 1-2, 1999, Pages 11-36

  Burcham, Philip C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

DNA alkylation; DNA oxidation; Endogenous DNA adduct; Estrogen; Lipid peroxidation; Mutagenicity

Indexed keywords

ALKYLATING AGENT; AMINO ACID; DEOXYRIBONUCLEOTIDE; DIMETHYLNITROSAMINE; ESTROGEN; HEMOPROTEIN; OXIDIZING AGENT; RADICAL; S ADENOSYLMETHIONINE;

DNA DAMAGE; GLYCOSYLATION; HUMAN; LIPID PEROXIDATION; MUTAGENICITY; PRIORITY JOURNAL; REVIEW;

EID: 0033565934     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00008-3     Document Type: Article

References (239)

1. Nath R.G., Randerath K., Li D., Chung F.L. Endogenous production of DNA adducts. Regul. Toxicol. Pharmacol. 23:1996;22-28.
2. Bartsch H., Barbin A., Marion M.J., Nair J., Guichard Y. Formation, detection, and role in carcinogenesis of etheno bases in DNA. Drug Metab. Rev. 26:1994;349-371.
3. Marnett L.J., Burcham P.C. Endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol. 6:1993;771-785.
4. Okado A., Kawasaki Y., Hasuike Y., Takahashi M., Teshima T., Fujii J., Taniguchi N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 225:1996;219-224.
5. Ji C., Rouzer C.A., Marnett L.J., Pietenpol J.A. Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis. 19:1998;1275-1283.
6. Singer B., Hang B. What structural features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem. Res. Toxicol. 10:1997;713-732.
7. Krokan H.E., Standal R., Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem. J. 325:1997;1-16.
8. Khrapko K., Coller H.A., Andre P.C., Li X.C., Hanekamp J.S., Thilly W.G. Mitochondrial mutational spectra in human cells and tissues. Proc. Natl. Acad. Sci. USA. 94:1997;13798-13803.
9. Driggers W.J., Holmquist G.P., LeDoux S.P., Wilson G.L. Mapping frequencies of endogenous oxidative damage and the kinetic response to oxidative stress in a region of rat mtDNA. Nucleic Acids Res. 25:1997;4362-4369.
10. Wilson G.L., Patton N.J., LeDoux S.P. Mitochondrial DNA in β-cells is a sensitive target for damage by nitric oxide. Diabetes. 46:1997;1291-1295.
11. Yakes F.M., van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA. 94:1997;514-519.
12. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
13. Nestmann E.R., Bryant D.W., Carr C.J., Fennell T.T., Gallagher J.E., Gorelick N.J., Swenberg J.A., Williams G.M. Toxicological significance of DNA adducts: summary of discussions with an expert panel. Regul. Toxicol. Pharmacol. 24:1996;9-18.
14. Helbock H.J., Beckman K.B., Shigenaga M.K., Walter P.B., Woodall A.A., Yeo H.C., Ames B.N. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl. Acad. Sci. USA. 95:1998;288-293.
15. Duffy S., So A., Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71:1998;69-77.
16. Moraes E.C., Keyse S.M., Pidoux M., Tyrrell R.M. The spectrum of mutations generated by passage of a hydrogen peroxide damaged shuttle vector plasmid through a mammalian host. Nucleic Acids Res. 17:1989;8301-8312.
17. McBride T.J., Preston B.D., Loeb L.A. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry. 30:1991;207-213.
18. Farr S.B., D'Ari R., Touati D. Oxygen-dependent mutagenesis in Escherichia coli lacking superoxide dismutase. Proc. Natl. Acad. Sci. USA. 83:1986;8268-8272.
19. Abril N., Pueyo C. Mutagenesis in Escherichia coli lacking catalase. Environ. Mol. Mutagen. 15:1990;184-189.
20. Chary P., Dillon D., Schroeder A.L., Natvig D.O. Superoxide dismutase (sod-1) null mutants of Neurospora crassa: oxidative stress sensitivity, spontaneous mutation rate and response to mutagens. Genetics. 137:1994;723-730.
21. Sohal R.S., Agarwal A., Agarwal S., Orr W.C. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J. Biol. Chem. 270:1995;15671-15674.
22. Orr W.C., Sohal R.S. Extension of lifespan by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263:1994;1128-1130.
23. Larsen P.L. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 90:1993;8905-8909.
24. Touati D., Jacques M., Tardat B., Bouchard L., Despied S.J. Lethal oxidative damage and mutagenesis are generated by iron in delta fur mutants of Escherichia coli: protective role of superoxide dismutase. J. Bacteriol. 177:1995;2305-2314.
25. Gaziev A.I., Podlutsky A.J., Panfilov B.M., Bradbury R. Dietary supplements of antioxidants reduce hprt mutant frequency in splenocytes of aging mice. Mutat. Res. 338:1995;77-86.
26. Wood M.L., Dizdaroglu M., Gajewski E., Essigmann J.M. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine). Biochemistry. 29:1990;7024-7032.
27. Michaels M.L., Miller J.H. The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J. Bacteriol. 174:1992;6321-6325.
28. Glassner B.J., Posnick L.M., Samson L.D. The influence of DNA glycosylases on spontaneous mutation. Mutat. Res. 400:1998;33-44.
29. Tajiri T., Maki H., Sekiguchi M. Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat. Res. 336:1995;257-267.
30. Tkeshelashvili L.K., McBride T., Spence K., Loeb L.A. Mutation spectrum of copper-induced DNA damage. J. Biol. Chem. 266:1991;6401-6406.
31. Feig D.I., Sowers L.C., Loeb L.A. Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc. Natl. Acad. Sci. USA. 91:1994;6609-6613.
32. Kreutzer D.A., Essigmann J.M. Oxidized, deaminated cytosines are a source of C→T transitions in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;3578-3582.
33. Wagner J.R., Hu C.C., Ames B.N. Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. USA. 89:1992;3380-3384.
34. Basu A.K., Loechler E.L., Leadon S.A., Essigmann J.M. Genetic effects of thymine glycol: site-specific mutagenesis and molecular modeling studies. Proc. Natl. Acad. Sci. USA. 86:1989;7677-7681.
35. Chaung W., Boorstein R.J. Molecular spectrum of mutations induced by 5-hydroxymethyl-2′-deoxyuridine in (CHO)-PL61 cells. Mutat. Res. 373:1997;125-137.
36. Jenner A., England T.G., Aruoma O.I., Halliwell B. Measurement of oxidative DNA damage by gas chromatography-mass spectrometry: ethanethiol prevents artefactual generation of oxidized DNA bases. Biochem. J. 331:1998;365-369.
37. Kamiya H., Kasai H. Mutations induced by 2-hydroxyadenine on a shuttle vector during leading and lagging strand syntheses in mammalian cells. Biochemistry. 36:1997;11125-11130.
38. Kamiya H., Kasai H. Substitution and deletion mutations induced by 2-hydroxyadenine in Escherichia coli: effects of sequence contexts in leading and lagging strands. Nucleic Acids Res. 25:1997;304-311.
39. Loft S., Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74:1996;297-312.
40. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1997;1196-1203.
41. Fuciarelli A.F., Wegher B.J., Gajewski E., Dizdaroglu M., Blakely W.F. Quantitative measurement of radiation-induced base products in DNA using gas chromatography-mass spectrometry. Radiat. Res. 119:1989;219-231.
42. Dizdaroglu M., Gajewski E. Selected-ion mass spectrometry: assays of oxidative DNA damage. Methods Enzymol. 186:1990;530-544.
43. Olinski R., Zastawny T., Budzbon J., Skokowski J., Zegarski W., Dizdaroglu M. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 309:1992;193-198.
44. Jaruga P., Zastawny T.H., Skokowski J., Dizdaroglu M., Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 341:1994;59-64.
45. Cadet J., Douki T., Ravanat J.L. Artifacts associated with the measurement of oxidized DNA bases. Environ. Health Perspect. 105:1997;1034-1039.
46. Ravanat J.L., Turesky R.J., Gremaud E., Trudel L.J., Stadler R.H. Determination of 8-oxoguanine in DNA by gas chromatography-mass spectrometry and HPLC-electrochemical detection: overestimation of the background level of the oxidized base by the gas chromatography-mass spectrometry assay. Chem. Res. Toxicol. 8:1995;1039-1045.
47. 32P -postlabelling assay Carcinogenesis. 18:1997;2415-2419.
48. Collins A., Cadet J., Epe B., Gedik C. Problems in the measurement of 8-oxoguanine in human DNA. Carcinogenesis. 18:1997;1833-1836. Report of a workshop, DNA oxidation, held in Aberdeen, UK, 19-21 January, 1997.
49. 33P -postlabelling and electrochemical detection Carcinogenesis. 18:1997;2367-2371.
50. Ames B.N., Gold L.S. The prevention of cancer. Drug Metab. Rev. 30:1998;201-223.
51. Wagner B.A., Buettner G.R., Burns C.P. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry. 33:1994;4449-4453.
52. Chung F.L., Chen H.J., Nath R.G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis. 17:1996;2105-2111.
53. Burcham P.C. Genotoxic lipid peroxidation products: a review of their DNA-damaging properties and role in the formation of endogenous DNA adducts. Mutagenesis. 13:1988;287-305.
54. Garner B., Witting P.K., Waldeck A.R., Christison J.K., Raftery M., Stocker R. Oxidation of high density lipoproteins: I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol. J. Biol. Chem. 273:1998;6080-6087.
55. Viner R.I., Ferrington D.A., Aced G.I., Miller-Schlyer M., Bigelow D.J., Schoneich C. In vivo aging of rat skeletal muscle sarcoplasmic reticulum Ca-ATPase. Chemical analysis and quantitative simulation by exposure to low levels of peroxyl radicals. Biochim. Biophys. Acta. 1329:1997;321-335.
56. Greenley T.L., Davies M.J. Direct detection of radical generation in rat liver nuclei on treatment with tumour-promoting hydroperoxides and related compounds. Biochim. Biophys. Acta. 1226:1994;56-64.
57. Harkin L.A., Butler L.M., Burcham P.C. Role of G→T transversions in the mutagenicity of alkylperoxyl radicals: induction of alkali-labile sites in bacteriophage M13mp19. Chem. Res. Toxicol. 10:1997;575-581.
58. P.C. Burcham, L.A. Harkin, Mutations at G:C base-pairs predominate after replication of peroxyl radical-damaged pSP189 plasmids in human cells, Mutagenesis (in press).
59. Niki E. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol. 186:1990;100-108.
60. Martini M., Termini J. Peroxy radical oxidation of thymidine. Chem. Res. Toxicol. 10:1997;234-241.
61. 1-oxidised abasic sites in alkylperoxyl radical-damaged plasmid DNA. Biochem. Biophys. Res. Commun. 237:1997;1-5.
62. Bose K.N., Fonkeng B.S., Moghaddas S., Stroup D. Mechanisms of DNA damage by chromium(V) carcinogens. Nucleic Acids Res. 26:1998;1588-1596.
63. Valentine M.R., Rodriguez H., Termini J. Mutagenesis by peroxy radical is dominated by transversions at deoxyguanosine. Evidence for the lack of involvement of 8-oxo-dG and/or abasic site formation. Biochemistry. 37:1998;7030-7038.
64. Haring M., Rudiger H., Demple B., Boiteux S., Epe B. Recognition of oxidized abasic sites by repair endonucleases. Nucleic Acids Res. 22:1994;2010-2015.
65. H. Esterbauer, Aldehydic products of lipid peroxidation, in: D.C.H. McBrien, T.F. Slater (Eds.), Free Radicals, Lipid Peroxidation, and Cancer, Academic Press, London, 1982, pp. 101-128.
66. Liu J., Yeo H.C., Doniger S.J., Ames B.N. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal. Biochem. 245:1997;161-166.
67. Yeo H.C., Helbock H.J., Chyu D.W., Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220:1994;391-396.
68. Requena J.R., Fu M.X., Ahmed M.U., Jenkins A.J., Lyons T.J., Baynes J.W., Thorpe S.R. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322:1997;317-325.
69. L.J. Marnett, DNA adducts of α,β-unsaturated aldehydes and dicarbonyl compounds, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, D. Segerback, H. Bartsch, (Eds.), DNA Adducts: Identification and Biological Significance, IARC Scientific Publications, Vol. 125, IARC, Lyon, pp. 151-163.
70. Marnett L.J., Tuttle M.A. Comparison of the mutagenicities of malondialdehyde and the side-products formed during its chemical synthesis. Cancer Res. 40:1980;276-282.
71. Yau T.M. Mutagenicity and cytotoxicity of malonaldehyde in mammalian cells. Mech. Ageing Dev. 11:1979;137-144.
72. Spalding J.W. Toxicology and carcinogenesis studies of malondialdehyde sodium salt (3-hydroxy-2-propenal, sodium salt) in F344/N rats and B6C3F1 mice. Natl. Toxicol. Program Tech. Rep. Ser. 331:1988;5-13.
73. Fink S.P., Reddy G.R., Marnett L.J. Mutagenicity in Escherichia coli of the major DNA adduct formed from the endogenous mutagen, malondialdehyde. Proc. Natl. Acad. Sci. USA. 94:1997;8652-8657.
74. Chaudhary A.K., Nokubo M., Reddy G.R., Yeola A.N., Morrow J.D., Blair I.A., Marnett L.J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 265:1994;1580-1582.
75. 32P -postlabelling determination of DNA adducts of malonaldehyde in humans: total white blood cells and breast tissue Carcinogenesis. 16:1995;1847-1851.
76. Rouzer C.A., Chaudhary A.K., Nokubo M., Ferguson D.M., Reddy G.R., Blair I.A., Marnett L.J. Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. Chem. Res. Toxicol. 10:1997;181-188.
77. Toyokuni S., Luo X.P., Tanaka T., Uchida K., Hiai H., Lehotay D.C. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radical Biol. Med. 22:1997;1019-1027.
78. Zlatkis A., Poole C.F., Brazeli R., Bafus D.A., Spencer P.S. Volatile metabolites in sera of normal and diabetic patients. J. Chromatogr. 182:1980;137-145.
79. Rauli S., Puppo M.D., Magni F., Kienle M.G. Validation of malondialdehyde and 4-hydroxy-2-trans-nonenal measurement in plasma by NICI-GC-MS. J. Biochem. (Tokyo). 123:1998;918-923.
80. Selley M.L. Determination of the lipid peroxidation product (E)-4-hydroxy-2-nonenal in clinical samples by gas chromatography-negative-ion chemical ionisation mass spectrometry of the O-pentafluorobenzyl oxime. J. Chromatogr., B: Biomed. Sci. Appl. 691:1997;263-268.
81. Dittberner U., Eisenbrand G., Zankl H. Genotoxic effects of the alpha, beta-unsaturated aldehydes 2-trans-butenal, 2-trans-hexenal and 2-trans, 6-cis-nonadienal. Mutat. Res. 335:1995;259-265.
82. Eckl P.M., Ortner A., Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat. Res. 290:1993;183-192.
83. Cohen S.M., Garland E.M., St.-John M., Okamura T., Smith R.A. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res. 52:1992;3577-3581.
84. Chung F.L., Tanaka T., Hecht S.S. Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res. 46:1986;1285-1289.
85. Eder E., Hoffman C. Identification and characterization of deoxyguanosine adducts of mutagenic β-alkyl-substituted acrolein congeners. Chem. Res. Toxicol. 6:1993;486-494.
86. 2-(1,3-propano)-2′-deoxyguanosine 3′-phosphate adducts formed from 4-hydroxy-2-nonenal Chem. Res. Toxicol. 10:1997;1259-1265.
87. 2-ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res. 48:1988;320-323.
88. Sodum R.S., Chung F.-L. Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Res. 51:1991;137-143.
89. Chen H.J., Chung F.L. Formation of etheno adducts in reactions of enals via autoxidation. Chem. Res. Toxicol. 7:1994;857-860.
90. Chen H.J., Chung F.L. Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide. Chem. Res. Toxicol. 9:1996;306-312.
91. 4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res. Toxicol. 8:1995;278-283.
92. Marnett L.J., Hurd H.K., Hollstein M.C., Levin D.E., Esterbauer H., Ames B.N. Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat. Res. 148:1985;25-34.
93. Burcham P.C., Marnett L.J. Site-specific mutagenesis by a propanodeoxyguanosine adduct carried on an M13 genome. J. Biol. Chem. 269:1994;28844-28850.
94. Kawanishi M., Matsuda T., Sasaki G., Yagi T., Matsui S., Takebe H. A spectrum of mutations induced by crotonaldehyde in shuttle vector plasmids propagated in human cells. Carcinogenesis. 19:1998;69-72.
95. Palejwala V.A., Simha D., Humayun M.Z. Mechanisms of mutagenesis by exocyclic DNA adducts. Transfection of M13 viral DNA bearing a site-specific adduct shows that ethenocytosine is a highly efficient RecA-independent mutagenic noninstructional lesion. Biochemistry. 30:1991;8736-8743.
96. Moriya M., Zhang W., Johnson F., Grollman A.P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA. 91:1994;11899-11903.
97. 6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry. 35:1996;11487-11492.
98. 2-ethenoguanine, 5,6,7,9-tetrahydro-9-oxoimidazo[1, 2-a]purine, and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1, 2-a]purine. Biochemistry. 37:1998;5184-5193.
99. 2-propanodeoxy-guanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res. 56:1996;452-456.
100. 2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc. Natl. Acad. Sci. USA. 91:1994;7491-7495.
101. 2-(1,3-propano)-2′-deoxyguanosine adducts in mammalian cells. Chem. Res. Toxicol. 9:1996;1207-1213.
102. 32P -postlabelling Carcinogenesis. 16:1995;613-617.
103. Nair J., Sone H., Nagao M., Barbin A., Bartsch H. Copper-dependent formation of miscoding etheno-DNA adducts in the liver of Long-Evans cinnamon (LEC) rats developing hereditary hepatitis and hepatocellular carcinoma. Cancer Res. 56:1996;1267-1271.
104. 4-ethenodeoxycytidine (εdC) DNA adducts in liver of patients with Wilson's Disease and primary hemochromatosis. Proc. Am. Assoc. Cancer Res. 37:1996;117.
105. Dipple A., Moschel R.C., Hudgins W.R. Selectivity of alkylation and aralkylation of nucleic acid components. Drug Metab. Rev. 13:1982;249-268.
106. 6-alkylguanine. FASEB J. 6:1992;2302-2310.
107. Prevost V., Shuker D.E. Cigarette smoking and urinary 3-alkyladenine excretion in man. Chem. Res. Toxicol. 9:1996;439-444.
108. 7-methyldeoxyguanosine Cancer Res. 50:1990;6580-6584.
109. 32P -postlabelling analysis of 7-methylguanine in human bronchial and lymphocyte DNA Carcinogenesis. 14:1990;151-154.
110. Saffhill R., Margison G.P., O'Connor P.J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta. 823:1985;111-145.
111. Cussac C., Laval F. Reduction of the toxicity and mutagenicity of aziridine in mammalian cells harboring the Escherichia coli fpg gene. Nucleic Acids Res. 24:1990;1742-1746.
112. Karran P., Lindahl T., Ofsteng I., Evensen G.B., Seeberg E. Escherichia coli mutants deficient in 3-methyladenine-DNA glycosylase. J. Mol. Biol. 140:1980;101-127.
113. Encell L., Shuker D.E., Foiles P.G., Gold B. The in vitro methylation of DNA by a minor groove binding methyl sulfonate ester. Chem. Res. Toxicol. 9:1996;563-567.
114. Engelward B.P., Allan J.M., Dreslin A.J., Kelly J.D., Wu M.M., Gold B., Samson L.D. A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome. J. Biol. Chem. 273:1998;5412-5418.
115. 4-methylthymine in Escherichia coli using double-stranded and gapped plasmids. Carcinogenesis. 19:1998;457-461.
116. 6-methylguanine in wild-type Escherichia coli and in a strain deficient in ada-methyltransferase. J. Bacteriol. 173:1991;1201-1207.
117. 6-methylguanine in cells with different DNA repair backgrounds. Chem. Res. Toxicol. 9:1996;980-987.
118. Xiao W., Samson L. In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc. Natl. Acad. Sci. USA. 90:1993;2117-2121.
119. 6-methylguanine DNA repair methyltransferase. J. Bacteriol. 173:1991;2068-2076.
120. Rydberg B., Lindahl T. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J. 1:1982;211-216.
121. 4-ethylthymine in human liver and peripheral blood leukocyte DNA. Carcinogenesis. 16:1995;1277-1280.
122. Sagai M., Ichinose T. Age-related changes in lipid peroxidation as measured by ethane, ethylene, butane and pentane in respired gases of rats. Life Sci. 27:1980;731-738.
123. Filser F.G., Csanady G.A., Denk B., Hartmann M., Kauffmann A., Kessler W., Kreuzer P.E., Putz C., Shen J.H., Stei P. Toxicokinetics of isoprene in rodents and humans. Toxicology. 113:1996;278-287.
124. Bolt H.M. Quantification of endogenous carcinogens. The ethylene oxide paradox. Biochem. Pharmacol. 52:1996;1-5.
125. Walker V.E., MacNeela J.P., Swenberg J.A., Turner M.J., Fennell T.R. Molecular dosimetry of ethylene oxide: formation and persistence of N-(2-hydroxyethyl)valine in hemoglobin following repeated exposures of rats and mice. Cancer Res. 52:1992;4320-4327.
126. Walker V.E., Fennell T.R., Upton P.B., Skopek T.R., Prevost V., Shuker D.E., Swenberg J.A. Molecular dosimetry of ethylene oxide: formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice. Cancer Res. 52:1992;4328-4334.
127. Leclercq L., Laurent C., De Pauw E. High-performance liquid chromatography/electrospray mass spectrometry for the analysis of modified bases in DNA: 7-(2-hydroxyethyl)guanine, the major ethylene oxide-DNA adduct. Anal. Chem. 69:1997;1952-1955.
128. Bolt H.M., Leutbecher M., Golka K. A note on the physiological background of the ethylene oxide adduct 7-(2-hydroxyethyl)guanine in DNA from human blood. Arch. Toxicol. 71:1997;719-721.
129. 6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis. 18:1997;1561-1567.
130. 6-methylguanine in DNA. Cancer Res. 57:1997;366-369.
131. 6-(carboxymethyl)-2′-deoxyguanosine: a DNA adduct formed by nitrosated glycine derivatives. Chem. Res. Toxicol. 10:1997;652-659.
132. Taverna P., Sedgwick B.J. Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coli. J. Bacteriol. 178:1996;5105-5111.
133. S. Warren, P.M. LeCompte, M.A. Legg, Cancer and Diabetes, The Pathology of Diabetes Mellitus, 4th edn., Chap. 24, Lea and Febiger, Philadelphia, 1966, pp. 434-439.
134. Odani H., Shinzato T., Usami J., Matsumoto Y., Brinkmann Frye E., Baynes J.W., Maeda K. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS Lett. 427:1998;381-385.
135. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:1996;9982-9986.
136. Wells-Knecht K.J., Brinkmann E., Wells-Knecht M.C., Litchfield J.E., Ahmed M.U., Reddy S., Zyzak D.V., Thorpe S.R., Baynes J.W. New biomarkers of Maillard reaction damage to proteins. Nephrol. Dial. Transplant. 11(5):1996;41-47. Suppl.
137. Wells-Knecht M.C., Thorpe S.R., Baynes J.W. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:1995;15134-15141.
138. Knecht K.J., Feather M.S., Baynes J.W. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. Arch. Biochem. Biophys. 294:1992;130-137.
139. Brandt R.B., Siegel S.A. Methylglyoxal production in human blood. Ciba Found. Symp. 67:1978;211-223.
140. Vlassara H., Fuh H., Makita Z., Krungkrai S., Cerami A., Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. USA. 89:1992;12043-12047.
141. Soulis T., Cooper M.E., Vranes D., Bucala R., Jerums G. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int. 50:1996;627-634.
142. Soulis T., Cooper M.E., Sastra S., Thallas V., Panagiotopoulos S., Bjerrum O.J., Jerums G. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia. 40:1997;1141-1151.
143. Thornalley P.J. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem. Biol. Interact. 111-112:1998;137-151.
144. Bucala R., Model P., Cerami A. Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc. Natl. Acad. Sci. USA. 81:1984;105-109.
145. Bucala R., Model P., Russel M., Cerami A. Modification of DNA by glucose 6-phosphate induces DNA rearrangements in an Escherichia coli plasmid. Proc. Natl. Acad. Sci. USA. 82:1985;8439-8442.
146. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245:1987;243-250.
147. Hunt J.V., Dean R.T., Wolff S.P. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256:1988;205-212.
148. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 34:1995;3702-3709.
149. 2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry. 34:1995;648-655.
150. Nukaya H., Inaoka Y., Ishida H., Tsuji K., Suwa Y., Wakabayashi K., Kosuge T. Modification of the amino group of guanosine by methylglyoxal and other alpha-ketoaldehydes in the presence of hydrogen peroxide. Chem. Pharm. Bull. 41:1993;649-653.
151. 32P -postlabelling method for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA adducts of methylglyoxal Carcinogenesis. 15:1994;1887-1894.
152. Vaca C.E., Nilsson J.A., Fang J.L., Grafstrom R.C. Formation of DNA adducts in human buccal epithelial cells exposed to acetaldehyde and methylglyoxal in vitro. Chem. Biol. Interact. 108:1998;197-208.
153. Kasai H., Hayami H., Yamaizumi Z., Saito H., Nishimura S. Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. Nucleic Acids Res. 12:1984;2127-2136.
154. Murata-Kamiya N., Kamiya H., Kaji H., Kasai H. Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells. Nucleic Acids Res. 25:1997;1897-1902.
155. Murata-Kamiya N., Kaji H., Kasai H. Types of mutations induced by glyoxal, a major oxidative DNA-damage product, in Salmonella typhimurium. Mutat. Res. 377:1997;13-16.
156. Dorado L., Ruis Montoya M.R., Rodriguez Mellado J.M. A contribution to the study of the structure-mutagenicity relationship for α-dicarbonyl compounds using the Ames test. Mutat. Res. 269:1992;301-306.
157. Murata-Kamiya N., Kamiya H., Iwamoto N., Kasai H. Formation of a mutagen, glyoxal, from DNA treated with oxygen free radicals. Carcinogenesis. 16:1995;2251-2253.
158. R.W. Ruddon, Cancer Biology, 2nd edn., Oxford Univ. Press, New York, 1987.
159. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1981;1191-1308.
160. Henderson B.E., Ross B.E., Pike M.C. Toward the primary prevention of cancer. Science. 254:1991;1131-1138.
161. Liehr J.G., Avitts T.A., Randerath E., Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc. Natl. Acad. Sci. USA. 83:1986;5301-5305.
162. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36:1996;203-232.
163. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 19:1998;1-27.
164. Bradlow H.L., Hershcopf R.J., Martucci C.P., Fishman F. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumour virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA. 82:1985;6295-6299.
165. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 19:1998;1-27.
166. Liehr J.G., Fang W.F., Sirbasku D.A., Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24:1986;353-356.
167. Liehr J.G., Ricci M.J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA. 93:1996;3294-3296.
168. Newbold R.R., Bullock B.C., McLachlan J.A. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 50:1990;7677-7681.
169. Zhu B.T., Liehr J.G. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 125:1994;149-158.
170. Lavigne J.A., Helzlsouer K.J., Huang H.Y., Strickland P.T., Bell D.A., Selmin O., Watson M.A., Hoffman S., Comstock G.W., Yager J.D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 57:1997;5493-5497.
171. Dwivedy I., Devanesan P., Cremonesi P., Rogan E., Cavalieri E. Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem. Res. Toxicol. 5:1992;828-833.
172. Stack D.E., Byun J., Gross M.L., Rogan E.G., Cavalieri E.L. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9:1996;851-859.
173. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA. 94:1997;10937-10942.
174. Roy D., Abul-Hajj Y.J. Estrogen-nucleic acid adducts: guanine is major site for interaction between 3,4-estrone quinone and COIII gene. Carcinogenesis. 18:1997;1247-1249.
175. Akanni A., Tabakovic K., Abul-Hajj Y.J. Estrogen-nucleic acid adducts: reaction of 3,4-estrone o-quinone with nucleic acid bases. Chem. Res. Toxicol. 10:1997;477-481.
176. Han X., Liehr J.G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54:1994;5515-5517.
177. Han X., Liehr J.G. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis. 15:1994;997-1000.
178. Wyllie S., Liehr J.G. Enhancement of estrogen-induced renal tumorigenesis in hamsters by dietary iron. Carcinogenesis. 19:1998;1285-1290.
179. Han X., Liehr J.G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis. 16:1995;2571-2574.
180. Itoh S., Yamauchi A., Itoh Y., Takagi H., Yoshizawa I. Reaction of adenine with 6-hydroxyestrogen 6-sulfates: model compounds to demonstrate carcinogenesis by estrogen. Chem. Pharm. Bull. (Tokyo). 44:1996;1754-1757.
181. Terashima I., Suzuki N., Itoh S., Yoshizawa I., Shibutani S. Mutagenic specificity of model estrogen-DNA adducts in mammalian cells. Biochemistry. 37:1998;8803-8807.
182. Shibutani S., Itoh S., Yoshizawa I. Miscoding properties of model estrogen-DNA adducts in reactions catalyzed by mammalian and Escherichia coli DNA polymerases. Biochemistry. 36:1997;1755-1765.
183. Service R.F. New role for estrogen in cancer? Science. 279:1998;1631-1633.
184. ·) in the carcinogenic process. Biochim. Biophys. Acta. 1288:1996;F31-F36.
185. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711-721.
186. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1994;1001-1003.
187. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
188. Routledge M.N., Wink D.A., Keefer L.K., Dipple A. DNA sequence changes induced by two nitric oxide donor drugs in the supF assay. Chem. Res. Toxicol. 7:1994;628-632.
189. Duncan B.K., Miller J.H. Mutagenic deamination of cytosine residues in DNA. Nature. 287:1980;560-561.
190. Kamiya H., Shimizu M., Suzuki M., Inoue H., Ohtsuka E. Mutation induced by deoxyxanthosine in codon 12 of a synthetic c-Ha-ras gene. Nucleosides Nucleotides. 11:1992;247-260.
191. Coulondre C., Miller J.H., Farabaugh P.J., Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature. 274:1978;775-780.
192. Caulfield J.L., Wishnok J.S., Tannenbaum S.R. Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J. Biol. Chem. 273:1998;12689-12695.
193. Rubbo H., Darley-Usmar V., Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9:1996;809-820.
194. Douki T., Cadet J. Peroxynitrite-mediated oxidation of purine bases of nucleosides and isolated DNA. Free Radical Res. 24:1996;369-380.
195. Kennedy L.J., Moore K., Caulfield J.L., Tannenbaum S.R., Dedon P.C. Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents. Chem. Res. Toxicol. 10:1997;386-392.
196. Spencer J.P., Wong J., Jenner A., Aruoma O.I., Cross C.E., Halliwell B. Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Chem. Res. Toxicol. 9:1996;1152-1158.
197. Yermilov V., Rubio J., Becchi M., Friesen M.D., Pignatelli B., Ohshima H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis. 16:1995;2045-2050.
198. Juedes M.J., Wogan G.N. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. 349:1996;51-61.
199. E.C. Friedberg, DNA Repair, Freeman, New York, 1984.
200. Koppenol W.H. Peroxynitrite uncloaked? Chem. Res. Toxicol. 11:1998;716-717.
201. Yermilov V., Rubio J., Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 376:1995;207-210.
202. Jeong J.K., Juedes M.J., Wogan G.N. Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: relevance to peroxynitrite mutagenesis. Chem. Res. Toxicol. 11:1998;550-556.
203. Squadrito G.L., Pryor W.A. The nature of reactive species in systems that produce peroxynitrite. Chem. Res. Toxicol. 11:1998;718-719.
204. Caulfield J.L., Singh S.P., Wishnok J.S., Deen W.M., Tannenbaum S.R. Bicarbonate inhibits N-nitrosation in oxygenated nitric oxide solutions. J. Biol. Chem. 271:1996;25859-25863.
205. Yermilov V., Yoshie Y., Rubio J., Ohshima H. Effects of carbon dioxide/bicarbonate on induction of DNA single-strand breaks and formation of 8-nitroguanine, 8-oxoguanine and base-propenal mediated by peroxynitrite. FEBS Lett. 399:1996;67-70.
206. Schraufstatter I.U., Browne K., Harris A., Hyslop P.A., Jackson J.H., Quehenberger O., Cochrane C.G. Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. 85:1990;554-562.
207. Handelman G.J., Nightingale Z.D., Dolnikowski G.G., Blumberg J.B. Formation of carbonyls during attack on insulin by submolar amounts of hypochlorite. Anal. Biochem. 258:1998;339-348.
208. Wlodkowski T.J., Rosenkranz H.S. Mutagenicity of sodium hypochlorite for Salmonella typhimurium. Mutat. Res. 31:1975;39-42.
209. 2 with the ethidium-binding assay. J. Biochem. Biophys. Methods. 32:1996;125-135.
210. Whiteman M., Jenner A., Halliwell B. Hypochlorous acid-induced base modifications in isolated calf thymus DNA. Chem. Res. Toxicol. 10:1997;1240-1246.
211. A. Kappas, S. Sassa, R.A. Galbraith, Y. Nordmann, The porphyrias, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, 7th edn., Vol. II, McGraw-Hill, New York, 1995, pp. 2103-2160.
212. R.A. Goyer, Toxic effects of metals, in: C.D. Klaassen (Ed.), Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th edn., McGraw-Hill, New York, 1995, pp. 691-736.
213. S.A. Schroeder, L.M. Tierney, S.J. McPhee, M.A. Papdakis, M.A. Krupp (Eds.), Appendix, Clinical Chemistry, Current Medical Diagnosis and Treatment, Prentice-Hall, Englewood Cliffs, NJ, 1992, pp. 1278-1280.
214. Minder E.I. Measurement of 5-aminolaevulinic acid by reversed-phase HPLC and fluorescence detection. Clin. Chim. Acta. 161:1986;11-18.
215. Kauppinen R., Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br. J. Cancer. 57:1988;117-120.
216. Gubler J.G., Bargetzi M.J., Meyer U.A. Primary liver carcinoma in two sisters with acute intermittent porphyria. Am. J. Med. 89:1990;540-541.
217. Hiraku Y., Kawanishi S. Mechanism of oxidative DNA damage induced by δ-aminolevulinic acid in the presence of copper ion. Cancer Res. 56:1996;1786-1793.
218. Monteiro H.P., Abdalla D.S., Faljoni-Alario A., Bechara E.J. Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and δ-aminolevulinic acid. Biochim. Biophys. Acta. 881:1986;100-106.
219. Monteiro H.P., Abdalla D.S., Augusto O., Bechara E.J. Free radical generation during δ-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpathies. Arch. Biochem. Biophys. 271:1989;206-216.
220. Fraga C.G., Onuki J., Lucesoli F., Bechara E.J., Di Mascio P. 5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2′-deoxyguanosine in DNA. Carcinogenesis. 15:1994;2241-2244.
221. 2+ ions. Biochim. Biophys. Acta. 1225:1994;259-263.
222. Oteiza P.I., Kleinman C.G., Demasi M., Bechara E.J. 5-Aminolevulinic acid induces iron release from ferritin. Arch. Biochem. Biophys. 316:1995;607-611.
223. Douki T., Onuki J., Medeiros M.H., Bechara E.J., Cadet J., Di Mascio P. DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid. Chem. Res. Toxicol. 11:1998;150-157.
224. Fiedler D.M., Eckl P.M., Krammer B. Does δ-aminolaevulinic acid induce genotoxic effects? J. Photochem. Photobiol. B. 33:1996;39-44.
225. Glatt H., Protic-Sablji C.M., Oesch F. Mutagenicity of glutathione and cysteine in the Ames test. Science. 220:1983;961-963.
226. Glatt H. Endogenous mutagens derived from amino acids. Mutat. Res. 238:1990;235-243.
227. G.A. Mitchell, M. Lambert, R.M. Tanguay, Hypertyrosinemia, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, 7th edn., Vol. I, McGraw-Hill, New York, 1995, pp. 1077-1106.
228. Hiraku Y., Yamasaki M., Kawanishi S. Oxidative DNA damage induced by homogentisic acid, a tyrosine metabolite. FEBS Lett. 432:1998;13-16.
229. Deutsch J.C., Santhosh-Kumar C.R. Quantitation of homogentisic acid in normal human plasma. J. Chromatogr., B: Biomed. Appl. 677:1996;147-151.
230. B.N. La Du, Alkaptonuria, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, 7th edn., Vol. I, McGraw-Hill, New York, 1995, pp. 1371-1386.
231. Weinberg A.G., Mize C.E., Worthen H.G. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J. Pediatr. 88:1976;434-438.
232. Jorquera R., Tanguay R.M. The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochem. Biophys. Res. Commun. 232:1997;42-48.
233. Dedon P.C., Plastaras J.P., Rouzer C.A., Marnett L.J. Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. Proc. Natl. Acad. Sci. USA. 95:1998;11113-11116.
234. Kadlubar F.F., Anderson K.E., Haussermann S., Lang N.P., Barone G.W., Thompson P.A., MacLeod S.L., Chou M.W., Mikhailova M., Plastaras J., Marnett L.J., Nair J., Velic I., Bartsch H. Comparison of DNA adduct levels associated with oxidative stress in humans. Mutat. Res. 405:1998;125-133.
235. 32P -postlabelling assay Mutat. Res. 378:1997;1-12.
236. 2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res. 58:1998;581-584.
237. Dittberner U., Schmetzer B., Golzer P., Eisenbrand G., Zankl H. Genotoxic effects of 2-trans-hexenal in human buccal mucosa cells in vivo. Mutat. Res. 390:1997;161-165.
238. Harris C.C. The 1995 Walter Hubert Lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br. J. Cancer. 73:1996;261-269.
239. Lutz W.K., Fekete T., Vamvakas S. Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology. Environ. Health Perspect. 106:1998;207-211.